MRI-guided ablation no better than conventional PVI for Atrial Fibrillation
Key Points: DECAAF-1 showed that higher volumes of atrial tissue fibrosis on…
ENVISAGE-TAVI AF shows edoxaban noninferior to VKAs in patients with AFib after TAVR.
Key Points: ENVISAGE-TAVI AF is a large, multinational, randomized-control trial investigate the…
Finerenone not only slows progression of kidney disease, but prevents cardiovascular events as well: results from FIGARO-DKD
Key Points: …
Haemodynamic Guided Heart Failure Management as a Hospitalization Reduction Strategy – the GUIDE-HF Tria
KEY POINTS: · CardioMEMS, a wireless, battery-free pressure sensor implanted in the…
SMART-MI shows Benefits of Cardiac Monitoring after Myocardial Infarction
KEY POINTS: Implantable Cardioverter Defibrillators (ICDs) are indicated for post-myocardial infarction patients…
Empagliflozin does it again: Results from EMPEROR-PRESERVED
Key Points: Patients with chronic heart failure with preserved ejection fraction (HFpEF,…
Novel IL-6 Antibody Crushes CRP in High-risk ASCVD in Phase2
RESCUE, a phase II, trial presented by Paul M. Ridker, MD, Director of…
Colder Is Not Necessarily Better: CAPITAL CHILL Results
Key Points: Survivors of out of hospital cardiac arrest (OHCA) suffer very…
Role for Omecamtiv Mecarbil in Pts with EF
KEY POINTS: An experimental new therapeutic for heart failure, omecamtiv mecarbil is…
Revascularization Shows Benefit at 4 years in ISCHEMIA
Key Points: ISCHEMIA trial patients in the invasive management arm were assessed…
Acute alcohol consumption elevates risk of AF event
Presented as a Late Breaking Clinical Trial at the American College of…
Radiation-Induced Cardiac Disease
During the third and last day of the 2021 American College of…
Hyperinvasive Approach Improves Survival in Refractory Out-of-Hospital Cardiac Arrest
It goes without saying that refractory out of hospital cardiac arrest (OHCA)…
No Advantage to Catheter Ablation for Rhythm Control in Atrial Fibrillation
Atrial fibrillation and heart failure are two common, costly medical conditions that…
Hospital-level Intervention Did Not Improve Outcomes or Quality in HFrEF
Key Points: CONNECT-HF, one of the largest heart failure (HF) implementation science…
Pirfenidone Shown to Decrease Fibrosis in Patients with HFpEF
Key Points: Myocardial fibrosis has previously been associated with death and repeat…
Benefits of Sotagliflozin Across Full Spectrum of EF
KEY POINTS: Trials for those with heart failure with preserved ejection fraction…
Transfusion in AMI: More or Less?
A restrictive transfusion strategy may no longer be inferior to a liberal…
Sacubitril/Valsartan Not More Effective Than Valsartan alone in Advanced HF: LIFE trial
Key Points: This is the first study to assess the effects of…
0/1hr or 0/3hr hsTroponin T in Suspected ACS?
Key Points: Among patients with suspected acute coronary syndromes (ACS) and ischemia…